Home › Funds › Transmarket Holdings LP › GSK

Transmarket Holdings LP position in GSK

GSK PLC · Health Care

Transmarket Holdings LP reported holding 188,473 shares of GSK (GSK PLC) in its Q2 2026 13F filing — a position valued at US$9.9M, representing 7.25% of its reported portfolio and ranking #3 among its reported holdings. Transmarket Holdings LP has disclosed GSK holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)188.47K sh
Reported value held$9.88M
Portfolio Weight7.25%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

How Transmarket Holdings LP's GSK position evolved

Transmarket Holdings LP first disclosed a stake in GSK in Q4 2025 at 27,816 shares (US$1.4M). The position peaked in Q1 2026 at 222,457 shares, worth US$12.3M. Across 3 filings, Transmarket Holdings LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 188,473 shares valued at US$9.9M — a reduction of -33,984 shares quarter over quarter.. Notable position changes include a 700% increase in Q1 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 27.82K $1.36M New
Q1 2026 222.46K $12.28M Add
Q2 2026 188.47K $9.88M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →